Cargando…

Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease

In this study, we explored the clinical value of next-generation metagenome sequencing (mNGS) using bronchoalveolar lavage fluid (BALF) samples from patients with acid-fast staining (AFS) sputum smear-negative pulmonary tuberculosis (PTB) and non-tuberculous mycobacterial pulmonary disease (NTM-PD)....

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peng, Yang, Ke, Yang, Lei, Wang, Zhongli, Jin, Fang, Wang, Yubao, Feng, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283093/
https://www.ncbi.nlm.nih.gov/pubmed/35847073
http://dx.doi.org/10.3389/fmicb.2022.898195
_version_ 1784747259662958592
author Xu, Peng
Yang, Ke
Yang, Lei
Wang, Zhongli
Jin, Fang
Wang, Yubao
Feng, Jing
author_facet Xu, Peng
Yang, Ke
Yang, Lei
Wang, Zhongli
Jin, Fang
Wang, Yubao
Feng, Jing
author_sort Xu, Peng
collection PubMed
description In this study, we explored the clinical value of next-generation metagenome sequencing (mNGS) using bronchoalveolar lavage fluid (BALF) samples from patients with acid-fast staining (AFS) sputum smear-negative pulmonary tuberculosis (PTB) and non-tuberculous mycobacterial pulmonary disease (NTM-PD). Data corresponding to hospitalized patients with pulmonary infection admitted to the hospital between July 2018 and July 2021, who were finally diagnosed with AFS sputum smear-negative PTB and NTM-PD, were retrospectively analyzed. Bronchoscopy data as well as mNGS, Xpert, AFS (BALF analysis), and T-SPOT (blood) data, were extracted from medical records. Thereafter, the diagnostic performances of these methods with respect to PTB and NTM-PD were compared. Seventy-one patients with PTB and 23 with NTM-PD were included in the study. The sensitivities of mNGS, Xpert, T-SPOT, and AFS for the diagnosis of PTB were 94.4% (67/71), 85.9% (61/71), 64.8% (46/71), and 28.2% (20/71), respectively, and the diagnostic sensitivity of mNGS combined with Xpert was the highest (97.2%, 67/71). The specificity of Xpert was 100%, while those of AFS and T-SPOT were 73.9% (17/23) and 91.3% (21/23), respectively. Further, the 23 patients with NTM-PD could be identified using mNGS, and in the population with immunosuppression, the sensitivities of mNGS, Xpert, T-SPOT, and AFS were 93.5% (29/31), 80.6% (25/31), 48.4% (15/31), and 32.3% (10/31), respectively, and the diagnostic sensitivity of mNGS combined with Xpert was the highest (100%, 31/31). The specificities of Xpert and T-SPOT in this regard were both 100%, while that of AFS was 40% (2/5). Furthermore, using mNGS, all the NTM samples could be identified. Thus, the analysis of BALF samples using mNGS has a high accuracy in the differential diagnosis of MTB and NTM. Further, mNGS combined with Xpert can improve the detection of MTB, especially in AFS sputum smear-negative samples from patients with compromised immune states or poor responses to empirical antibiotics.
format Online
Article
Text
id pubmed-9283093
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92830932022-07-16 Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease Xu, Peng Yang, Ke Yang, Lei Wang, Zhongli Jin, Fang Wang, Yubao Feng, Jing Front Microbiol Microbiology In this study, we explored the clinical value of next-generation metagenome sequencing (mNGS) using bronchoalveolar lavage fluid (BALF) samples from patients with acid-fast staining (AFS) sputum smear-negative pulmonary tuberculosis (PTB) and non-tuberculous mycobacterial pulmonary disease (NTM-PD). Data corresponding to hospitalized patients with pulmonary infection admitted to the hospital between July 2018 and July 2021, who were finally diagnosed with AFS sputum smear-negative PTB and NTM-PD, were retrospectively analyzed. Bronchoscopy data as well as mNGS, Xpert, AFS (BALF analysis), and T-SPOT (blood) data, were extracted from medical records. Thereafter, the diagnostic performances of these methods with respect to PTB and NTM-PD were compared. Seventy-one patients with PTB and 23 with NTM-PD were included in the study. The sensitivities of mNGS, Xpert, T-SPOT, and AFS for the diagnosis of PTB were 94.4% (67/71), 85.9% (61/71), 64.8% (46/71), and 28.2% (20/71), respectively, and the diagnostic sensitivity of mNGS combined with Xpert was the highest (97.2%, 67/71). The specificity of Xpert was 100%, while those of AFS and T-SPOT were 73.9% (17/23) and 91.3% (21/23), respectively. Further, the 23 patients with NTM-PD could be identified using mNGS, and in the population with immunosuppression, the sensitivities of mNGS, Xpert, T-SPOT, and AFS were 93.5% (29/31), 80.6% (25/31), 48.4% (15/31), and 32.3% (10/31), respectively, and the diagnostic sensitivity of mNGS combined with Xpert was the highest (100%, 31/31). The specificities of Xpert and T-SPOT in this regard were both 100%, while that of AFS was 40% (2/5). Furthermore, using mNGS, all the NTM samples could be identified. Thus, the analysis of BALF samples using mNGS has a high accuracy in the differential diagnosis of MTB and NTM. Further, mNGS combined with Xpert can improve the detection of MTB, especially in AFS sputum smear-negative samples from patients with compromised immune states or poor responses to empirical antibiotics. Frontiers Media S.A. 2022-07-01 /pmc/articles/PMC9283093/ /pubmed/35847073 http://dx.doi.org/10.3389/fmicb.2022.898195 Text en Copyright © 2022 Xu, Yang, Yang, Wang, Jin, Wang and Feng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Xu, Peng
Yang, Ke
Yang, Lei
Wang, Zhongli
Jin, Fang
Wang, Yubao
Feng, Jing
Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease
title Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease
title_full Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease
title_fullStr Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease
title_full_unstemmed Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease
title_short Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease
title_sort next-generation metagenome sequencing shows superior diagnostic performance in acid-fast staining sputum smear-negative pulmonary tuberculosis and non-tuberculous mycobacterial pulmonary disease
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283093/
https://www.ncbi.nlm.nih.gov/pubmed/35847073
http://dx.doi.org/10.3389/fmicb.2022.898195
work_keys_str_mv AT xupeng nextgenerationmetagenomesequencingshowssuperiordiagnosticperformanceinacidfaststainingsputumsmearnegativepulmonarytuberculosisandnontuberculousmycobacterialpulmonarydisease
AT yangke nextgenerationmetagenomesequencingshowssuperiordiagnosticperformanceinacidfaststainingsputumsmearnegativepulmonarytuberculosisandnontuberculousmycobacterialpulmonarydisease
AT yanglei nextgenerationmetagenomesequencingshowssuperiordiagnosticperformanceinacidfaststainingsputumsmearnegativepulmonarytuberculosisandnontuberculousmycobacterialpulmonarydisease
AT wangzhongli nextgenerationmetagenomesequencingshowssuperiordiagnosticperformanceinacidfaststainingsputumsmearnegativepulmonarytuberculosisandnontuberculousmycobacterialpulmonarydisease
AT jinfang nextgenerationmetagenomesequencingshowssuperiordiagnosticperformanceinacidfaststainingsputumsmearnegativepulmonarytuberculosisandnontuberculousmycobacterialpulmonarydisease
AT wangyubao nextgenerationmetagenomesequencingshowssuperiordiagnosticperformanceinacidfaststainingsputumsmearnegativepulmonarytuberculosisandnontuberculousmycobacterialpulmonarydisease
AT fengjing nextgenerationmetagenomesequencingshowssuperiordiagnosticperformanceinacidfaststainingsputumsmearnegativepulmonarytuberculosisandnontuberculousmycobacterialpulmonarydisease